<DOC>
	<DOCNO>NCT00318188</DOCNO>
	<brief_summary>Systemic sclerosis ( SSc ) connective-tissue disease characterize excessive collagen deposition , vascular hyper-reactivity obliterative microvascular phenomenon lead disability , handicap , worsen quality life . Pharmacological treatment mainly use vascular involvement . To date , pharmacological treatment show effective fibrosis lead skin , tendon , joint disability . Our hypothesis rehabilitation could interest non pharmacological treatment order decrease handicap SSc patient . Our objective evaluate effect personalize standardized rehabilitation program quality life SSc patient multicentric randomize controlled trial . This trial compare personalize standardized rehabilitation program usual non pharmacological treatment . The primary outcome measure HAQ DI ( Health Assessment Questionnaire Disability Index ) . A Zelen design use study .</brief_summary>
	<brief_title>Effects Personalized Standardized Rehabilitation Program Systemic Sclerosis</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Scleroderma , Systemic</mesh_term>
	<mesh_term>Scleroderma , Diffuse</mesh_term>
	<criteria>Men woman age 18 year , diagnostic SSc consider ACR and/or Leroy Medsger 's criterion . HAQ great equal 0.5 A perception limitation mouth open and/or least one limitation range motion due illness Good understand French language Exclusion Criteria : Associated chronic handicap disease ( stroke , multiple sclerosis , amyotrophic lateral sclerosis , Parkinson 's disease , amputate ... . ) Any underlying disease may incompatible management , discovery inclusion visit Cognitive problem make impossible assess primary outcome measure Patients standardized rehabilitation program within 6 month prior inclusion Impairment comprehension expression French language Patients participate another clinical trial participate another clinical trial previous 3 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>scleroderma</keyword>
	<keyword>HAQ</keyword>
	<keyword>Intensive care reeducation , readaptation</keyword>
</DOC>